Dec 2 (Reuters) - The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical toxicity studies for certain monoclonal antibodies. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback